Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Hungary Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20142
20153
20183
20195
20201
20211
20223
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated7
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Gilead Sciences2
AbbVie1
Amgen1
AstraZeneca1
ERYtech Pharma1
ETOP IBCSG Partners Foundation1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms21
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung2
Melanoma2
Neoplasm Metastasis2
Squamous Cell Carcinoma of Head and Neck2
Uterine Cervical Neoplasms2
Adenocarcinoma of Lung1
Carcinoma, Hepatocellular1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.